Registry of Lobbyists
| Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
| Associated registration: | 778662-371-23 |
| Communication date: | 2012-02-01 |
| Posted date: | 2012-03-16 |
| Designated Public Office Holders who participated in the communication: |
Paul Glover,
Assistant Deputy Minister
Health Canada (HC) |
| Subject Matter of the communication: | Health, Industry |
| Communication Report amended on: | 2012-03-13 previous entry: 371-211846 |
| Reason for amendment: | Noticed that a "subject matter" was missing and therefore, there was a need to add the matter, which resulted in this amendment. |
| Responsible Officer who filed this communication report: | RUSSELL WILLIAMS |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |